Diabetic Macular Edema is a common cause of vision loss
in diabetics suffering from the effects of diabetic retinopathy. We are
fortunate to have a number of treatment options including injections of Vascular
Endothelial Growth Inhibitor (VEGF) drugs such as Lucentis® & Eyelea® that
are helpful to treat and reverse the effects of Diabetic Macular Edema.
Researchers reporting in the British Journal of Ophthalmology shared helpful information about the
importance of the VEGF inhibitor
injection frequency and duration in the treatment of diabetic macular
edema. The study confirmed that patients
need to be patient as their ophthalmologists plan and schedule their
examinations, testing and visits as sometime the best results can only be
achieved multiple injections over some period of time. In general good long
term results are achieved by about 4 months of injection treatment, but 20% of
patients with persistent Diabetic Macular Edema at 12 months achieved a dry
macula with considerable restoration of vision with sustained treatment through
24 months suggesting that persistent
Diabetic Macular Edema at 4-12 months should not be used as a stopping
criterion for treatment.
If
you or someone you know has a question about diabetic retinopathy including
diabetic macular edema with Lucentis® or Eyelea® injections please
feel free to call Northwest Indiana Eye
& Laser Center at 219-464-8223,
or visit Northwest Indiana
Eye & Laser Center
or facebook.com/nwindianaeyeandlaser
to schedule an appointment.
Northwest Indiana Eye & Laser
Center offices are located at 522 Marquette Street, Valparaiso, Indiana 46383
and 1001 South Edgewood Drive, Knox, Indiana 46354.
No comments:
Post a Comment